The acquisition of pulmonary function testing solutions partner Morgan Scientific will strengthen Vitalograph’s US presence and capacity to meet the growing demand for respiratory diagnostics solutions.
RT’s Three Key Takeaways:
- Vitalograph Acquires Morgan Scientific: Vitalograph has acquired its long-term partner Morgan Scientific, a developer of software for pulmonary function testing, to expand its respiratory diagnostics business globally.
- Strengthened Pulmonary Testing Solutions: The integration of Morgan Scientific’s ComPAS2 software with Vitalograph’s pulmonary function testing systems is expected to advance the development of Vitalograph’s diagnostic solutions for better lung health assessment.
- Long-Standing Partnership Formalized: The acquisition marks the culmination of a long-term partnership between the companies, leveraging their combined expertise to focus on innovation and customer service in the respiratory diagnostics space.
Respiratory diagnostics provider Vitalograph has acquired long-term partner Morgan Scientific, the company that developed ComPAS2 and the software behind Vitalograph’s range of pulmonary function testing solutions.
Vitalography says in a release that the acquisition strengthens its US commercial footprint and enables it to meet the growing global demand for respiratory diagnostics solutions.
“We have a long and successful relationship with Morgan Scientific. This agreement is the natural progression for both companies as our combined expertise allows us to focus on delivering the best possible diagnostic solutions that can enable a better understanding of lung health,” says Frank Keane, CEO of Vitalograph, in a release.
Morgan Scientific is a provider of customer-facing software for advanced pulmonary function testing systems. ComPAS2, the company’s flagship software, powers Vitalograph’s range of pulmonary function testing solutions, the VitaloPFT Series. Morgan Scientific is also a key distributor for Vitalograph’s pulmonary function testing solutions in the US.
“The recent creation of the VitaloPFT Series has given us valuable experience in working as a team and built mutual respect for our individual expertise,” says Keane in a release. “Morgan Scientific is a natural complement to the Vitalograph brand, and this development brings incredible value to our customers all over the world. This acquisition paves the way for us to develop our comprehensive [pulmonary function testing] range further.”
Gareth Morgan, son of the founder of Morgan Scientific, adds in a release, “There is no other company in the world that we trust to uphold our legacy of innovation and to continue to put the needs of customers at the forefront of every decision. Joining a globally present and renowned brand such as Vitalograph will enable us to concentrate our efforts on building the business through what we know best—excellence in innovation and customer service.”
Vitalograph has acquired Morgan Scientific as part of its strategy to expand its respiratory diagnostics business globally. The company aims to significantly increase its testing solutions to support respiratory healthcare and is on track to treble its respiratory diagnostics business in the four years leading to 2026.
Photo caption: Tasmin Sharley, Vitalograph clinical application specialist, demonstrates ComPAS2 software at ERS 2024 in Vienna.
Photo credit: Vitalograph
